You are here

Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Hradec Kralove, , 500 05 Czech Republic
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Overactive Bladder
Sex
Female
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Women > 18 years Old

- Diagnosis of OAB (micturition frequency >/= 8 times per day; urinary urgency >/= 4
times per week)

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects with symptoms of overactive bladder for less than 6 months prior to
randomization.

- Significant stress incontinence as determined by the investigator e.g. stress
predominant mixed incontinence, positive cough provocation test.

- Subjects with any condition that would contraindicate the use of tolterodine or
pregabalin, including: Uncontrolled narrow angle glaucoma; Urinary retention;
Myasthenia gravis; Gastric retention; Severe ulcerative colitis; Toxic megacolon; Rare
hereditary problems of galactose intolerance; Fructose intolerance; Sucrose-isomalate
insufficiency; Lapp lactase deficiency; Glucose-galactose malabsorption.

NCT00746681
Pfizer
Completed
Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Overactive Bladder (OAB)
NCT00282932
Males
40+
Years
Multiple Sites
Treatment of Overactive Bladder
NCT00902187
All Genders
18+
Years
New Haven, Connecticut
Overactive Bladder
NCT00658684
All Genders
20+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now